Generalizability of the REDUCE-IT Trial in Patients With Stable Coronary Artery Disease

Epidemiological studies suggest that both moderate and severe hypertriglyceridemia are associated with increased long-term cardiovascular risk and mortality. Interestingly, the REDUCE-IT (Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention) randomized trial recently enrolled 8,179